A new Covid-19 variant, PJ.2.1, is attracting attention after being detected in several countries following its identification in Canada in May 2026. The variant has since been reported in the United States, Singapore, Australia, New Zealand, Israel, France and Spain. A study published in the Journal of Infection in October 2026 examined the variant's genetic characteristics, spread and response to antibodies generated by variant-adapted Covid vaccines. PJ.2.1 originated from MC.10.1.7, a descendant of the JN.1 lineage. Researchers described it as a "saltation variant", referring to a virus with a substantial number of genetic changes. The study found that PJ.2.1 showed increased ability to enter certain human cell lines. However, it did not demonstrate substantially greater ability to evade antibodies from people who had received the LP.8.1-adapted vaccine. Researchers said further surveillance is needed to understand how the variant behaves in real-world conditions. Dr Saraf, quoted in the Indian Express report, said laboratory findings indicated increased interaction with the ACE2 receptor, which the virus uses to enter human cells. However, faster spread does not automatically mean more severe disease. Real-world evidence about hospitalisations and clinical outcomes is still needed. Experts quoted in the report said there is currently no evidence that PJ.2.1 causes more severe illness or hospitalisation than earlier variants. They advised people in India not to panic but to continue taking sensible precautions. Older adults and people with diabetes, heart or lung conditions, or weakened immunity may be more vulnerable to complications. People experiencing fever, persistent cough, sore throat or breathing difficulty should seek medical advice. Wearing a well-fitting mask in crowded or poorly ventilated spaces, improving indoor ventilation and maintaining hand hygiene are practical precautions. People at higher risk should also discuss their vaccination status with their doctors. The emergence of PJ.2.1 is a reminder that Covid-19 continues to evolve and that monitoring, early attention to symptoms and timely medical care remain important.
Fast-Spreading Covid Variant PJ.2.1: What Indians Need to Know
A new Covid-19 variant, PJ.2.1, first identified in Canada in May 2026, has been detected in several countries. Experts say there is no confirmed evidence that it causes more severe illness, but older adults and people with existing health conditions should remain cautious.


0 comments
No comments yet. Yours would be the first.